申请人:Merck Sharp & Dohme Corp.
公开号:US08039484B2
公开(公告)日:2011-10-18
Diaryl ethers in which one of the aryl groups is a phenyl fused to a cycloalkyl or heterocyclic ring, to which is attached an acetic acid group, are agonists of G-protein coupled receptor 40 (GPR40) and are useful as therapeutic compounds, particularly in the treatment of Type 2 diabetes mellitus, and of conditions that often accompany this disease, including insulin resistance, obesity and lipid disorders.
苯基与环状烷基或杂环基融合,并附有乙酸基的二芳基醚类化合物,是G蛋白偶联受体40 (GPR40) 的激动剂,可用作治疗化合物,特别是用于治疗2型糖尿病,以及常伴随该病的胰岛素抵抗、肥胖和脂质异常等疾病的治疗。